| Cefuroxime |
ІІ-14616/23.10.2006 г. |
XORIMAX, Coated tablet, 500 mg, -, Pack: 10 |
Sandoz GmbH, Австрия |
Sandoz GmbH Austria |
14.32 |
2.86 |
17.18 |
6% |
0.86 |
15.18 |
3.04 |
18.22 |
18% |
2.58 |
17.76 |
3.55 |
21.31 |
КЦ-136/
04,07,2008 г. |
29.07.2008 |
29.07.2008 |
|
|
Активен |
7152 |
| Sennae acutifoliae fructus extr. sicc. normatum |
20020506 |
X-PREP, Oral solution, 2.34g/75 ml, -, Pack: 1 |
Mundipharma GmbH, Австрия |
Mundipharma GmbH, Germany |
4.44 |
0.89 |
5.33 |
7% |
0.31 |
4.75 |
0.95 |
5.7 |
20% |
0.89 |
5.64 |
1.13 |
6.77 |
НСР-2263/21.12.2013 |
27.01.2014 |
27.01.2014 |
|
|
Активен |
8670 |
| Enzalutamide |
EU/1/13/846/002 |
Xtandi, Film coated tablet, 40, mg, Pack: 112 |
Astellas Pharma Europe B.V., Нидерландия |
Astellas Pharma Europe B.V., Нидерландия |
5168.95 |
1033.79 |
6202.74 |
4% |
10 |
5178.95 |
1035.79 |
6214.74 |
16% |
25 |
5203.95 |
1040.79 |
6244.74 |
НСР-19270/18.07.2019; НСР-20568/16.01.2020 |
02.08.2019 |
02.02.2020 |
|
|
Заличен |
16624 |
| Enzalutamide |
EU/1/13/846/002 |
Xtandi, Film coated tablet, 40, mg, Pack: 112 |
Astellas Pharma Europe B.V., Нидерландия |
Astellas Pharma Europe B.V., Нидерландия |
5168.95 |
1033.79 |
6202.74 |
4% |
10 |
5178.95 |
1035.79 |
6214.74 |
16% |
25 |
5203.95 |
1040.79 |
6244.74 |
НСР-19270/18.07.2019 |
02.08.2019 |
02.09.2019 |
|
|
Неактивен |
16624 |
| Dalbavancin |
EU/1/14/ 986/001 |
Xydalba, powder for concetrate for solution for infusion, 500 mg, -, Pack: 1 |
Durata Therapeu-tics Internatio-nal B.V., Нидерландия |
Almac Pharma Services Ltd, UK |
1486.43 |
297.29 |
1783.72 |
4% |
10 |
1496.43 |
299.29 |
1795.72 |
16% |
25 |
1521.43 |
304.29 |
1825.72 |
НСР-7288/29.10.2015. |
14.11.2015 |
14.11.2015 |
|
|
Активен |
9145 |
| Lidocaine, Chlorhexidine |
II-1947/17,04,2008 |
XYLODREN BROWN, Solution for injection, 2 ml, -, Pack: 10 |
Софарма АД, България |
СОФАРМА АД |
5.76 |
1.15 |
6.91 |
7% |
0.4 |
6.16 |
1.23 |
7.39 |
20% |
1.15 |
7.31 |
1.46 |
8.77 |
КЦ-131/
23,06,2008 г. |
22.07.2008 |
22.07.2008 |
|
|
Активен |
7957 |
| Lidocaine, Chlorhexidine |
II-1947/17,04,2008 |
XYLODREN BROWN, Solution for injection, 2 ml, -, Pack: 50 |
Софарма АД, България |
СОФАРМА АД |
28.79 |
5.76 |
34.55 |
6% |
1.73 |
30.52 |
6.1 |
36.62 |
18% |
5.18 |
35.7 |
7.14 |
42.84 |
КЦ-131/
23,06,2008 г. |
22.07.2008 |
22.07.2008 |
|
|
Активен |
7956 |
| Xylometazoline |
20050202 |
XYLOGEL, nasal gel, 0,1 % - 10 g, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
5.09 |
1.02 |
6.11 |
7% |
0.36 |
5.45 |
1.09 |
6.54 |
20% |
1.02 |
6.47 |
1.29 |
7.76 |
НСР-1019/23.08.2013; НСР-12853/26.05.2017 |
19.09.2013 |
02.07.2017 |
|
|
Заличен |
8394 |
| Xylometazoline |
20050201 |
XYLOGEL, nasal gel, 0,05 % - 10 g, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
3.72 |
0.74 |
4.46 |
7% |
0.26 |
3.98 |
0.8 |
4.78 |
20% |
0.74 |
4.72 |
0.94 |
5.66 |
НСР-1020/23.08.2013; НСР-11580/26.01.2017 |
19.09.2013 |
02.03.2017 |
|
|
Заличен |
8395 |
| Xylometazoline hydrochloride |
20050202 |
XYLOGEL, nasal gel, 0,1 % - 10 g, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
5.09 |
1.02 |
6.11 |
7% |
0.36 |
5.45 |
1.09 |
6.54 |
20% |
1.02 |
6.47 |
1.29 |
7.76 |
НСР-1019/23.08.2013 |
19.09.2013 |
19.09.2013 |
|
|
Неактивен |
8394 |
| Xylometazoline hydrochloride |
20050201 |
XYLOGEL, nasal gel, 0,05 % - 10 g, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
3.72 |
0.74 |
4.46 |
7% |
0.26 |
3.98 |
0.8 |
4.78 |
20% |
0.74 |
4.72 |
0.94 |
5.66 |
НСР-1020/23.08.2013 |
19.09.2013 |
19.09.2013 |
|
|
Неактивен |
8395 |
| Xylometazoline |
20030701 |
XYLOMETAZOLIN WZF, nasal drops, solution, 0,05 % - 10 ml, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
2.07 |
0.41 |
2.48 |
7% |
0.14 |
2.21 |
0.44 |
2.65 |
20% |
0.41 |
2.62 |
0.52 |
3.14 |
НСР-1022/23.08.2013; НСР-19689/29.08.19 |
13.09.2019 |
02.10.2019 |
|
|
Активен |
8397 |
| Xylometazoline |
20030702 |
XYLOMETAZOLIN WZF, nasal drops, solution, 0,1 % - 10 ml, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
1.6 |
0.32 |
1.92 |
7% |
0.11 |
1.71 |
0.34 |
2.05 |
20% |
0.32 |
2.03 |
0.41 |
2.44 |
НСР-1021/23.08.2013; НСР-12852/26.05.2017 |
19.09.2013 |
02.07.2017 |
|
|
Заличен |
8396 |
| Xylometazoline hydrochloride |
20030701 |
XYLOMETAZOLIN WZF, nasal drops, solution, 0,05 % - 10 ml, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
1.08 |
0.22 |
1.3 |
7% |
0.08 |
1.16 |
0.23 |
1.39 |
20% |
0.22 |
1.38 |
0.28 |
1.66 |
НСР-1022/23.08.2013 |
19.09.2013 |
19.09.2013 |
|
|
Неактивен |
8397 |
| Xylometazoline hydrochloride |
20030702 |
XYLOMETAZOLIN WZF, nasal drops, solution, 0,1 % - 10 ml, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
1.6 |
0.32 |
1.92 |
7% |
0.11 |
1.71 |
0.34 |
2.05 |
20% |
0.32 |
2.03 |
0.41 |
2.44 |
НСР-1021/23.08.2013 |
19.09.2013 |
19.09.2013 |
|
|
Неактивен |
8396 |
| Tiotropium bromide, Olodaterol |
20150258 |
Yanimo Respimat, Inhalation solution, 2.5 mcg/2.5 mcg, -, Pack: 1 инхалатор Respimat + 1 пълнител 4,0 ml (60 впръсквания или 30 лекарствени дози) |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co. KG, Германия |
69.43 |
13.89 |
83.32 |
4% |
2.78 |
72.21 |
14.44 |
86.65 |
16% |
11.11 |
83.32 |
16.66 |
99.98 |
НСР-16173/19.07.2018 г. (предварително изпълнение); НСР-17427/06.12.2018 |
19.07.2018 |
02.01.2019 |
|
|
Заличен |
16176 |
| Tiotropium bromide, Olodaterol |
20150258 |
Yanimo Respimat, Inhalation solution, 2.5 mcg/2.5 mcg, -, Pack: 1 инхалатор Respimat + 1 пълнител 4,0 ml (60 впръсквания или 30 лекарствени дози) |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co. KG, Германия |
69.43 |
13.89 |
83.32 |
4% |
2.78 |
72.21 |
14.44 |
86.65 |
16% |
11.11 |
83.32 |
16.66 |
99.98 |
НСР-16173/19.07.2018 г. (предварително изпълнение) |
19.07.2018 |
02.08.2018 |
|
|
Неактивен |
16176 |
| Ethinylestradiol, Drospirenone |
II-14288/27.09.2006
20010803 |
YASMIN, Film coated tablet, 0,03 mg/3 mg, -, Pack: 21 |
Bayer Schering Pharma AG,, Германия |
Bayer Schering Pharma AG, Germany;
Schering GmbH and Co Produktion KG, Germany |
10.8 |
2.16 |
12.96 |
6% |
0.65 |
11.45 |
2.29 |
13.74 |
18% |
1.94 |
13.39 |
2.68 |
16.07 |
КЦ-352/
19,12,2008 г. |
22.01.2009 |
22.01.2009 |
|
|
Активен |
8053 |
| Donepezil |
20070118 |
YASNAL, Film coated tablet, 5 mg, -, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia; TAD Pharma GmbH, Германия |
7.92 |
1.58 |
9.5 |
7% |
0.55 |
8.47 |
1.69 |
10.16 |
20% |
1.58 |
10.05 |
2.01 |
12.06 |
НСР-8303/26.02.2016 |
02.04.2016 |
02.04.2016 |
|
|
Активен |
1725 |
| Donepezil |
20070119 |
YASNAL, Film coated tablet, 10 mg, -, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia; TAD Pharma GmbH, Германия |
11.89 |
2.38 |
14.27 |
6% |
0.71 |
12.6 |
2.52 |
15.12 |
18% |
2.14 |
14.74 |
2.95 |
17.69 |
НСР-8304/26.02.2016 |
02.04.2016 |
02.04.2016 |
|
|
Активен |
1724 |
| Donepezil |
№ II - 12796/ 01.04.2011 |
Yasnal Q-Tab, Orodispersible tablet, 5 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения; TAD Pharma GmbH, Germany |
40.92 |
8.18 |
49.1 |
4% |
1.64 |
42.56 |
8.51 |
51.07 |
16% |
6.55 |
49.11 |
9.82 |
58.93 |
КЦ-2890/06.10.2011 г. |
05.11.2011 |
05.11.2011 |
|
|
Активен |
7288 |
| Donepezil |
№ II - 12797/ 01.04.2011 |
Yasnal Q-Tab, Orodispersible tablet, 10 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения; TAD Pharma GmbH, Germany |
46.08 |
9.22 |
55.3 |
4% |
1.84 |
47.92 |
9.58 |
57.5 |
16% |
7.37 |
55.29 |
11.06 |
66.35 |
КЦ-2890/06.10.2011 г. |
05.11.2011 |
05.11.2011 |
|
|
Активен |
7287 |
| Ethinylestradiol, Drospirenone |
ІІ-4643/09.04.2009 |
Yaz, Film coated tablet, 0,02 mg/3,0 mg, -, Pack: 28 |
Bayer Schering Pharma AG,, Германия |
Bayer Schering Pharma AG, Germany; Schering GmbH & Co Producion KG, Germany |
14.67 |
2.93 |
17.6 |
6% |
0.88 |
15.55 |
3.11 |
18.66 |
18% |
2.64 |
18.19 |
3.64 |
21.83 |
КЦ-1044/
22,07,2009 г. |
10.08.2009 |
10.08.2009 |
|
|
Активен |
8056 |
| Bromfenac |
EU/1/11/692/001 |
Yellox, Eye drops, solution, 0.9 mg/ml - 5 ml, -, Pack: 1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, Германия |
7.26 |
1.45 |
8.71 |
7% |
0.51 |
7.77 |
1.55 |
9.32 |
20% |
1.45 |
9.22 |
1.84 |
11.06 |
НСР-1482/21.10.2013 |
21.10.2013 |
02.12.2016 |
промяна на обстоятелства НСР-10895/10.11.2016 |
|
Активен |
8502 |
| Bromfenac |
EU/1/11/692/001 |
Yellox, Eye drops, solution, 0.9 mg/ml - 5 ml, -, Pack: 1 |
Croma Pharma GmbH,, Австрия |
Croma Pharma GmbH, Austria; Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, Германия |
7.26 |
1.45 |
8.71 |
7% |
0.51 |
7.77 |
1.55 |
9.32 |
20% |
1.45 |
9.22 |
1.84 |
11.06 |
НСР-1482/21.10.2013 |
21.10.2013 |
21.10.2013 |
|
|
Неактивен |
8502 |